New Parkinson’s trial platform could “dramatically speed up the search for a cure”

News

Author: Saskia MairPublished: 14 May 2020

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Scientists have proposed the use of a multi-arm, multi-stage trial platform (MAMS) to assess different potential treatments for Parkinson’s and help progress the search for a cure.

This would depart from conventional clinical procedures, allowing several potential treatments to be assessed simultaneously. In a continuous process, each treatment ‘arm’ is evaluated and unsuccessful ‘arms’ of the trial are dropped, enabling a far more cost and time efficient system.

Currently, MAMS are used to evaluate treatments for certain types of cancer – and work is underway to develop MAMS for other neurodegenerative conditions.

Camille Buchholz Carroll, associate professor at the University of Plymouth, UK, and study author, said that MAMS trials could “dramatically speed up the search for a cure”.

She said: “We have the opportunity to learn from the experience in these other conditions and design a new trial that will work for people with Parkinson’s.”

To read more on this topic click here.

For more information on the latest Parkinson’s research please visit the EPDA website.


Read more:

Can higher levels of caffeine and uric acid prevent Parkinson’s?

White blood cells could help diagnose people at risk of Parkinson’s, study finds

Go Back

Share this story

Comments


Related articles


Summit

Global update

Tickets on sale for ‘Insight into Parkinson’s’ summit 2019

Tickets for the online event are now on sale

READ MORE

Perspectives

“There is hope for turning this condition around”

Sheila Roy charts the 'life-changing' effects of new gene therapy

READ MORE
Service-dogs-lead

Perspectives

Paws for Parkinson’s: the perks and the quirks of service dogs

‘Man’s best friend’ can provide a stabilising presence

READ MORE